BioOrbit

BioOrbit, an in-space drug manufacturing company, has raised £9.8m in seed funding to accelerate its mission to manufacture pharmaceutical drugs in space at scale.

Summary of transaction details:

• Value: £9.8m
• Sector: DeepTech & AI
• Advisor: Not disclosed
• Key Entities: BioOrbit, LocalGlobe, Breega
• Location: Not disclosed

Note: This investment marks a significant milestone in the development of in-space manufacturing, enabling the production of high-value drugs at scale and in orbit for the first time, and has the potential to transform the pharmaceutical industry.